Featured Research

from universities, journals, and other organizations

How E. coli clone has become globally distributed

Date:
March 31, 2014
Source:
University of Plymouth
Summary:
Scientists have for the first time come closer to understanding how a clone of E. coli, described as the most important of its kind to cause human infections, has spread across the world in a very short time. E. coli clone ST131 is one of the leading causes of urinary tract and blood stream infections and has crossed the globe at a rapid rate. Worryingly, members of this clone are becoming more resistant to antibiotics. As an indication of scale, more than half of all women will suffer a urinary tract infection at least once in their lives.

Scientists have for the first time come closer to understanding how a clone of E. coli, described as the most important of its kind to cause human infections, has spread across the world in a very short time.

E. coli clone ST131 is one of the leading causes of urinary tract and blood stream infections and has crossed the globe at a rapid rate. Worryingly, members of this clone are becoming more resistant to antibiotics. As an indication of scale, more than half of all women will suffer a urinary tract infection at least once in their lives. An international team of scientists, led by the University of Queensland in Australia and with the UK work led by Plymouth University and the Cardiff University has studied ST131 and now has a better understanding of how it operates.

Their findings, published in theProceedings of the National Academy of Sciences (PNAS) USA, have two significant potential outcomes: the first and in the short term, enhanced screening of patients with either urinary tract or blood stream infection, so that those with ST131 receive appropriate treatment and management (ensuring that our most potent antibiotics are only used to treat severe infections caused by these resistant bacteria); and in the long term, the potential for the development of vaccines and other ways to control infection specific to this clone.

No one knows where or when ST131 came into being, but it is one of the most successful of its kind in terms of spread and invasiveness. It has become effective at causing infections and resisting antibiotics because it continually exchanges bits of DNA with other bacteria, a clever process which also gives it specific ways of hiding from the body's immune system.

The research team used genome sequencing to analyse strains of ST131 from six distinct geographical locations across the world spanning 2000 to 2011. Their work shows that, despite such a large geographical spread, the ST131 clone of E. coli came from a single ancestor, prior to the year 2000.

By isolating ST131's progression in this way, and understanding how it has been able to thrive, work can begin on the development of effective screening and vaccination strategies.

Dr. Mathew Upton, who led the study from Plymouth University, said: "The Chief Medical Officer has stated that antibiotic resistance is one of the leading threats to human health. We need to ensure that patients are treated, but we also need to be certain that we use the most appropriate antibiotic for the job. In a condition such as urinary tract infection, most patients will receive a 'best guess' diagnosis and treatment from their GP. While most will react favourably to the antibiotics they are given, others will not and in this case a possible culprit is E. coli ST131."

He added: "What we need to avoid is doctors using the few antibiotics that are effective against resistant ST131 for all cases of urinary tract infection, because it is seen to be the only therapeutic strategy that works. The outcome of this will be that all the other bacteria that contribute to urinary tract infection become resistant too, which in turn reduces the number of effective antibiotics available for treatment, especially for those patients who are really sick. Instead, we need to create effective screening processes for patients, to ensure that only those who are infected by ST131, and other drug resistant, virulent clones receive those 'reserve' antibiotics. Our global survey of ST131 E. coli is helping us to understand these bacteria in great detail and will support development of these urgently needed screening strategies.

"In time we can also use our findings to develop vaccines that are specific to ST131, but this solution is some years away."

Dr Tim Walsh from Cardiff University's School of Medicine added: "The paper describes the global distribution of an E. coli clone called ST131. This clone is recognised as a human pathogen and has collected additional DNA making it highly resistant and difficult to treat. The spread of these clones is due to economic globalization through international food exports and human travel."


Story Source:

The above story is based on materials provided by University of Plymouth. Note: Materials may be edited for content and length.


Journal Reference:

  1. N. K. Petty, N. L. Ben Zakour, M. Stanton-Cook, E. Skippington, M. Totsika, B. M. Forde, M.-D. Phan, D. Gomes Moriel, K. M. Peters, M. Davies, B. A. Rogers, G. Dougan, J. Rodriguez-Bano, A. Pascual, J. D. D. Pitout, M. Upton, D. L. Paterson, T. R. Walsh, M. A. Schembri, S. A. Beatson. Global dissemination of a multidrug resistant Escherichia coli clone. Proceedings of the National Academy of Sciences, 2014; DOI: 10.1073/pnas.1322678111

Cite This Page:

University of Plymouth. "How E. coli clone has become globally distributed." ScienceDaily. ScienceDaily, 31 March 2014. <www.sciencedaily.com/releases/2014/03/140331153612.htm>.
University of Plymouth. (2014, March 31). How E. coli clone has become globally distributed. ScienceDaily. Retrieved September 19, 2014 from www.sciencedaily.com/releases/2014/03/140331153612.htm
University of Plymouth. "How E. coli clone has become globally distributed." ScienceDaily. www.sciencedaily.com/releases/2014/03/140331153612.htm (accessed September 19, 2014).

Share This



More Plants & Animals News

Friday, September 19, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Raw: Elephant Undergoes Surgery in Tbilisi Zoo

Raw: Elephant Undergoes Surgery in Tbilisi Zoo

AP (Sep. 18, 2014) Grand the elephant has successfully undergone surgery to remove a portion of infected tusk at Tbilisi Zoo in Georgia. British veterinary surgeons used an electric drill to extract the infected piece. (Sept. 18) Video provided by AP
Powered by NewsLook.com
Chimp Violence Study Renews Debate On Why They Kill

Chimp Violence Study Renews Debate On Why They Kill

Newsy (Sep. 17, 2014) The study weighs in on a debate over whether chimps are naturally violent or become that way due to human interference in the environment. Video provided by Newsy
Powered by NewsLook.com
Some Tobacco Farmers Thrive Amid Challenges

Some Tobacco Farmers Thrive Amid Challenges

AP (Sep. 16, 2014) The South's tobacco country is surviving, and even thriving in some cases, as demand overseas keeps growers in the fields of one of America's oldest cash crops. (Sept. 16) Video provided by AP
Powered by NewsLook.com
Scientists Given Rare Glimpse of 350-Kilo Colossal Squid

Scientists Given Rare Glimpse of 350-Kilo Colossal Squid

AFP (Sep. 16, 2014) Scientists say a female colossal squid weighing an estimated 350 kilograms (770 lbs) and thought to be only the second intact specimen ever found was carrying eggs when discovered in the Antarctic. Duration: 00:47 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins